Stay updated on NVG-111 in ROR1+ Malignancies Clinical Trial
Sign up to get notified when there's something new on the NVG-111 in ROR1+ Malignancies Clinical Trial page.

Latest updates to the NVG-111 in ROR1+ Malignancies Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.3.2 was added and v3.2.0 was removed on the page; no visible changes to study details or other user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedThe page no longer displays the general government operating status notice that informed readers about potential delays and where to find status updates. This notice is unrelated to the trial details or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check35 days agoChange DetectedThe page content appears unchanged between screenshots; sections such as Study Overview, Eligibility Criteria, and Contacts remain the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check64 days agoChange DetectedSummary: The page updates its version from v3.1.0 to v3.2.0, adds a government-operating-status notice and a new clinical term (malignant lymphoma, large B-cell, diffuse), and retains the NIH Clinical Center operating info. The old version reference (v3.1.0) was removed.SummaryDifference4%

- Check71 days agoChange DetectedUpdates version from v3.0.2 to v3.1.0 and adds new contact details and phone number; no substantive changes to core content detected.SummaryDifference0.3%

- Check85 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2; 'Back to Top' removed. No changes to core content, pricing, stock, or time-slot availability.SummaryDifference0.2%

Stay in the know with updates to NVG-111 in ROR1+ Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NVG-111 in ROR1+ Malignancies Clinical Trial page.